Wednesday, September 4, 2013
Generic-Drug Giant Teva Prepping Specialty Drug For Japan
TOKYO (Nikkei)--Teva Pharmaceutical Industries Ltd. revealed progress Tuesday in its Japanese development of a specialty drug.
The Israeli company is the world's largest producer of generic drugs and holds the third-largest share of this market in Japan. But Teva also develops and sells specialty medications, and hopes to boost its name recognition and broaden sales of its generics by releasing new drugs in Japan.
Speaking at a Tokyo media conference Tuesday, Itzhak Krinsky, head of business development for Teva in the Asia-Pacific region, said the firm aims to roll out new drugs in Japan that have not yet been approved for marketing here.
Teva is currently in the final phase of clinical trials with its first specialty product for Japan: a multiple sclerosis drug that the company is already selling in more than 50 markets worldwide.
(The Nikkei, Sept. 4 morning edition)